Cystic fibrosis mortality and survival in the UK: 1947-2003
- PMID: 17182652
- DOI: 10.1183/09031936.00099506
Cystic fibrosis mortality and survival in the UK: 1947-2003
Abstract
Data up to 1995 on the survival of 3-yr cohorts of patients with cystic fibrosis (CF) born in the UK in the period 1968-1992 have previously been published. The present study reports survival data up to the end of 2003 together with a 2003 population estimate. All subjects with CF born in the UK in the period 1968-1992 were identified up to 1997 by active enquiry through recognised CF clinics and other hospital consultants. Information from the death certification authorities up to the end of 2003 was added. Death certificates that could not be matched with UK Cystic Fibrosis Survey records were investigated and the data reconciled. The observed survival up to 2003 of CF patients born in 1978 was 55% for males and 49% for females. For 1988 and 1992 the data were 91 and 88%, and 97 and 96%, respectively. The estimated 2003 mid-year CF population was 8,284. The continuing improvement in survival of cystic fibrosis patients in successive cohorts means that the previous prediction of median survival of >50 yrs of age for individuals born in 2000 continues to look realistic, even in the absence of proven effective therapy aimed at correcting the basic cystic fibrosis defect.
Similar articles
-
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.J Cyst Fibros. 2018 Mar;17(2):218-227. doi: 10.1016/j.jcf.2017.11.019. Epub 2018 Jan 6. J Cyst Fibros. 2018. PMID: 29311001 Free PMC article.
-
Cystic fibrosis mortality trend in Italy from 1970 to 2011.J Cyst Fibros. 2015 Mar;14(2):267-74. doi: 10.1016/j.jcf.2014.07.010. Epub 2014 Aug 20. J Cyst Fibros. 2015. PMID: 25151032
-
Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee.Thorax. 1999 May;54(5):420-2. doi: 10.1136/thx.54.5.420. Thorax. 1999. PMID: 10212106 Free PMC article.
-
Cystic fibrosis: paediatric aspects.Br J Hosp Med. 1996 Mar 6-19;55(5):241-7. Br J Hosp Med. 1996. PMID: 8777514 Review.
-
Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.J Pediatr. 2005 Sep;147(3 Suppl):S15-20. doi: 10.1016/j.jpeds.2005.08.009. J Pediatr. 2005. PMID: 16202775 Review.
Cited by
-
Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.PLoS One. 2012;7(7):e42241. doi: 10.1371/journal.pone.0042241. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860094 Free PMC article.
-
A web-based psychological support program for caregivers of children with cystic fibrosis: a pilot study.Health Qual Life Outcomes. 2015 Feb 4;13:11. doi: 10.1186/s12955-015-0211-y. Health Qual Life Outcomes. 2015. PMID: 25652684 Free PMC article.
-
Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability.J Bacteriol. 2012 Sep;194(17):4709-17. doi: 10.1128/JB.00566-12. Epub 2012 Jun 29. J Bacteriol. 2012. PMID: 22753064 Free PMC article.
-
Duration of intravenous antibiotic therapy in people with cystic fibrosis.Cochrane Database Syst Rev. 2016 Sep 1;9(9):CD006682. doi: 10.1002/14651858.CD006682.pub5. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2019 Sep 05;9:CD006682. doi: 10.1002/14651858.CD006682.pub6. PMID: 27582394 Free PMC article. Updated. Review.
-
Oxidative stress and impaired insulin secretion in cystic fibrosis pig pancreas.Adv Redox Res. 2022 Jul;5:100040. doi: 10.1016/j.arres.2022.100040. Epub 2022 Jun 9. Adv Redox Res. 2022. PMID: 35903252 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical